Nasal Spray Could Delay Alzheimer's by Years
An anti-Alzheimer's nasal spray that could delay the progress of the disease by years has been developed by scientists at ...
'We are very hopeful' | New nasal spray could delay Alzheimer's by years, researchers say
Researchers at Texas A&M University have developed a nasal spray shown to delay disease progression in animals -- fueling ...
Impacts3d
Tanning Nasal Sprays and Permatan: Are They the Future of Sunless Tanning?
Among the latest innovations are tanning nasal sprays and Permatan—two methods that have been generating buzz in the beauty ...
Scientists Develop Breakthrough Nasal Spray That Could Delay Alzheimer’s by Over a Decade
Research from the College of Medicine provides promising insights into delaying the progression of Alzheimer’s disease for ...
ALK snags EU and Canada rights to anaphylaxis nasal spray Neffy for $145m
ALK will also pay up to $320m in milestone payments to ARS in the deal, which sees the latter keep rights in the US, ...
Pharmacies are yanking cold medicines from shelves. So what are the options now?
The FDA has proposed ending the use of a common ingredient found in many cold and allergy medicines — and some pharmacies ...
healthcarepackaging1d
Automatic Assembly and Vial-filling Machine for Unidose Liquid Nasal Devices
TurboFil's fully automated UDS Vial Filling & Assembly System produces up to 100 unidose nasal spray devices per minute and ...
Yahoo1d
FDA says many cold medicines found over-the-counter don't work
"So there is a nose spray that still seems to have some benefit. But, pill version, your body breaks it down to the point ...
Nasal Drug Delivery Technology Market Breakthrough in Patient Care, Projected Market Growth to USD 7.8 Billion by 2031 - Market Research Intellect
The Nasal Drug Delivery Technology Market is driven by the rising demand for non-invasive administration methods that enhance patient compliance and bioavailability. Innovations such as advanced ...
CNET on MSN4d
Which Decongestants Are Effective? Why the FDA Wants to Pull a Popular Medicine Ingredient
Phenylephrine is included in many cold and flu products, but a scientific panel last year found that it doesn't really do its ...
ALK licenses rights to neffy®, the first approved adrenaline nasal spray for emergency treatment of allergic reactions (anaphylaxis)
ALK (ALKB:DC / OMX: ALK B) today announced that it has entered into a strategic license agreement with US-based ARS Pharmaceuticals, Inc. (“ARS Pharma”, NASDAQ: SPRY). The agreement grants ALK ...
Pharmabiz2d
ALK licenses rights to adrenaline nasal spray, neffy from ARS Pharma for emergency treatment of allergic reactions
The agreement grants ALK exclusive global rights to the neffy adrenaline (epinephrine) nasal spray, with exception of the USA, Australia, New Zealand, Japan and China. The deal delivers on key ...